Technical Analysis for GUTS - Fractyl Health, Inc.

Grade Last Price % Change Price Change
F 2.06 -5.94% -0.13
GUTS closed down 5.94 percent on Wednesday, November 20, 2024, on 82 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish -5.94%
Wide Bands Range Expansion -5.94%
Oversold Stochastic Weakness -5.94%
Spinning Top Other 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion 4.83%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 18 hours ago
Fell Below Previous Day's Low about 21 hours ago
Down 5% about 22 hours ago
Down 3% about 22 hours ago
Down 2 % about 22 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Fractyl Health, Inc. Description

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is based in Lexington, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Diabetes Gene Therapy Obesity

Is GUTS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.5
52 Week Low 1.74
Average Volume 357,454
200-Day Moving Average 5.00
50-Day Moving Average 2.50
20-Day Moving Average 2.50
10-Day Moving Average 2.26
Average True Range 0.26
RSI (14) 39.39
ADX 15.43
+DI 17.31
-DI 24.43
Chandelier Exit (Long, 3 ATRs) 2.69
Chandelier Exit (Short, 3 ATRs) 2.70
Upper Bollinger Bands 3.25
Lower Bollinger Band 1.75
Percent B (%b) 0.21
BandWidth 60.11
MACD Line -0.14
MACD Signal Line -0.09
MACD Histogram -0.054
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.37
Resistance 3 (R3) 2.39 2.31 2.32
Resistance 2 (R2) 2.31 2.23 2.30 2.30
Resistance 1 (R1) 2.18 2.18 2.14 2.16 2.28
Pivot Point 2.10 2.10 2.08 2.09 2.10
Support 1 (S1) 1.98 2.02 1.94 1.96 1.84
Support 2 (S2) 1.90 1.97 1.89 1.82
Support 3 (S3) 1.77 1.90 1.80
Support 4 (S4) 1.75